Cosentyx and Welts - a phase IV clinical study of FDA data

Summary:

Welts is reported as a side effect among people who take Cosentyx (secukinumab), especially for people who are female, 40-49 old, have been taking the drug for 1 - 6 months also take Taltz, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Welts when taking Cosentyx. It is created by eHealthMe based on reports of 187,010 people who have side effects when taking Cosentyx from the FDA, and is updated regularly.

What is Cosentyx?

Cosentyx has active ingredients of secukinumab. It is often used in psoriatic arthritis. eHealthMe is studying from 187,243 Cosentyx users. Check the latest studies of Cosentyx.

What is Welts?

Welts (bumps or swellings that occur on the outer skin layer) is found to be associated with 2,234 drugs and 2,065 conditions by eHealthMe. Check the latest studies of Welts.

On Jul, 18, 2025

187,010 people reported to have side effects when taking Cosentyx.
Among them, 262 people (0.14%) have Welts.

Among these 262 people:

How long have people been on Cosentyx when they have Welts? *

What is the gender of people who have Welts when taking Cosentyx? *

female: 53.82 %
male: 46.18 %

What is the age of people who have Welts when taking Cosentyx? *

What are other drugs people take besides Cosentyx? *

What are other side effects people have besides Welts? *

Itching: 70 people, 26.72%
Rashes (redness): 69 people, 26.34%
Urticaria (rash of round, red welts on the skin that itch intensely): 61 people, 23.28%
Drug Intolerance (drug sensitivity): 54 people, 20.61%
High Blood Pressure: 52 people, 19.85%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 52 people, 19.85%
Drug Ineffective: 46 people, 17.56%
Intestinal Haemorrhage (bleeding from intestine): 44 people, 16.79%
Oedema (fluid collection in tissue): 38 people, 14.50%
Dyspnea (difficult or laboured breathing): 37 people, 14.12%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 131 people, 50.00%
Psoriasis (immune-mediated disease that affects the skin): 108 people, 41.22%
Ankylosing Spondylitis (type of arthritis affecting the spine): 44 people, 16.79%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 15 people, 5.73%
Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 8 people, 3.05%
Muscle Aches (muscle pain): 8 people, 3.05%
Back Pain: 7 people, 2.67%
High Blood Pressure: 7 people, 2.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 2.67%
Pain: 4 people, 1.53%

* Approximation only. Some reports may have incomplete information.

Do you take Cosentyx and have Welts?

- Check whether Welts is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cosentyx:

Cosentyx (187,243 reports)

Welts treatments and more:

Welts (44,988 reports)

Common Cosentyx side effects:

Browse all side effects of Cosentyx:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common drugs associated with Welts:

Browse all the drugs that are associated with Welts:

Welts (2,234 drugs)

Common conditions associated with Welts:

Hbp: 9,685 reports
Pain: 1,063 reports
Pain relief: 1,050 reports
Rheumatoid arthritis: 833 reports
Asthma: 798 reports
Chronic asthma: 796 reports
Diabetes: 761 reports
Stroke: 725 reports
Type 2 diabetes mellitus: 675 reports
Blood cholesterol increased: 634 reports

Browse all the conditions that are associated with Welts:

Welts (2,065 conditions)

Drugs similar to Cosentyx and Welts :

How the study uses the data?

The study uses data from the FDA. It is based on secukinumab (the active ingredients of Cosentyx) and Cosentyx (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.